Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
175 Leser
Artikel bewerten:
(0)

Top Volume Stocks - Closing Review and The Week Ahead: Tamm Oil & Gas Corp, World Moto Inc, Amarantus Biosciences, Cellceutix Corp, Facebook Inc.

NEW YORK, December 28, 2012 /PRNewswire/ --

Top Volume Stocks OTC Watch List: Tamm Oil & Gas Corp (OTC: TAMO),World Moto,Inc. (OTC: FARE),Amarantus Biosciences (OTC: AMBS),Cellceutix Corp (OTC: CTIX,Facebook Inc (NASDAQ: FB).

Tamm Oil & Gas Corp (OTC: TAMO) came into focus in trading on Thursday after an impressive days trading based on price and volume. TAMO traded higher by 49% on $3 million traded which is heavy volume based on the average for that stock. We will keep our eye on TAMO today to see if it can build on those gains. The company also released news today which you can read below.

http://www.otcmarkets.com/stock/TAMO/news

World Moto (OTC: FARE) finally pulled back today after a fairly strong week of trading where we saw huge volume in a lightly traded week, and new highs set for the stock. FARE traded down in yesterday's trading by 25% on over $5 million traded. It remains to be seen if the follow through will happen in today's trading and we see FARE trade lower, or if the stock can recover which we have also seen before. Here is the volume trading chart for FARE in trading on Thursday.

http://www.otcmarkets.com/stock/FARE/chart

If you are looking to know what's going on with these companies on the OTC and in addition receive weekly picks on stocks that we feature….simply sign up at our website for free.

http://www.clubpennystock.com

Amarantus Biosciences (OTC: AMBS) was another stock that was having a good weeks trading but did trade down substantially in action on Wall Street in Thursdays trading. AMBS was lower by 30% on a heavily traded $4.5 million.

Cellceutix (OTC: CTIX) held up fairly well in trading on Thursday after its strong day earlier in this lightly traded week for Wall Street. CTIX was lower by just 1% on Thursday with $4.5 million traded on the OTC market.

Facebook (NASDAQ: FB) is a name that has interested many people. FB could now be at a price where the valuation is reasonable and the insiders have stopped selling shares. FB has traded down from $41.00 to approx. $26.00 per share and many experts are now saying that this is the time to be watching the stock. The volume is certainly lighter this week which may be positive as the hype may be down somewhat in this name which would ease the volatility. We will continue to keep you updated in the name going into 2013.

If you are looking to know what's going on with these companies on the OTC and in addition receive weekly picks on stocks that we feature….simply sign up at our website for free.

http://www.clubpennystock.com

The volume, although still light for this time of the year on the OTCQB market this week seems to be picking up in the last full trading week of the year.

Regardless of what's going on in the mainstream we will always keep you updated and look to be value added. We hope you have enjoyed our coverage today; we will be back to you on Friday with our look at the OTC markets.

We are making sure you are right in touch with all the top volume leaders in the penny stock world, and the lists of penny stocks. We will show you the movers and shakers and the companies making the headlines in our trading world.

We track the volume and keep in touch with any increasing trends to the upside or downside. We also cover the top stocks on the OTCQB, OTCQX, and the Pink Sheet markets.

As our subscribers know, timing is absolutely critical when buying stocks. The stocks you buy are not as important as when you buy.

Disclosure: Clubpennystocks is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Clubpennystocks is a wholly owned entity of a financial public relations firm. We have not been compensated by any of the companies listed in this news release.

Email:info@clubpennystocks.com

Tel: +1-561-417-7154


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.